 TORONTO, Sept. 06, 2022 GLOBE NEWSWIRE -- Profound Medical Corp. NASDAQ:PROF; TSX:PRN Profound or the Company, a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will participate in two investor conferences in September. 